The sialyl Lewis x oligosaccharide determinant is an essential component of leukocyte counterreceptors for E-selectin and P-selectin mediated adhesions of leukocytes. This oligosaccharide molecule is displayed on the surfaces of granulocytes, monocytes, and natural killer cells. Formation of leukocyte adhesions to these selectins is an early and important step in the process that ultimately allows leukocytes to leave the vascular tree and become recruited into lymphoid tissues and sites of inflammation. FUT7 was expressed in HL-60 cells, a human promyelocytic cell line, and in YT cells, a natural killer-like cell line. Sequence comparisons indicate that the predicted polypeptide sequence shares approximately 38 to 47% overall identity with other FUTs.
Rat Alpha- (1,3)-fucosyltransferase (FUT4) ELISA Kit employs a two-site sandwich ELISA to quantitate FUT4 in samples. An antibody specific for FUT4 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyFUT4 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for FUT4 is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of FUT4 bound in the initial step. The color development is stopped and the intensity of the color is measured.
Rat Alpha- (1,3)-fucosyltransferase (FUT4) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
Find more details at http://www.abbkine.com/product/rat-alpha-13-fucosyltransferase-fut4-elisa-kit-kte100895/
bio-equip.cn
Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.